Search results
Insider Sale: CEO Brian Goff Sells Shares of Agios Pharmaceuticals Inc (AGIO)
GuruFocus.com via Yahoo Finance· 4 days agoFollowing this transaction, the insider now owns 67,192 shares of the company. Agios Pharmaceuticals...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 11 hours agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients
Medical Xpress· 7 hours agoThere is no significant association between exposure to immunosuppressive therapies and development...
Pasco welcomes new pharmaceutical compounding firm
Tampa Bay Times· 1 day agoPharmacy has opened in the Asturia Corporate Center, part of what Pasco County is calling its “life sciences corridor” in Central Pasco, which will...
Ono Pharmaceutical wraps up $2.4 billion Deciphera buyout By Investing.com
Investing.com· 12 hours agoOno Pharmaceutical Co., Ltd. has successfully concluded the acquisition of Deciphera Pharmaceuticals...
WV among 42 states settling with pharmaceutical company over talc powder marketing
West Virginia Watch via Yahoo News· 3 hours agoWest Virginia is one of 42 states that have reached a $700 million settlement agreement with Johnson...
Johnson & Johnson settles baby powder asbestos claims for $700 million
Courthouse News Service· 5 hours agoThe pharmaceutical giant admitted no wrongdoing under the agreement and denies it violated the law....
...SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop...
Benzinga· 8 hours agoSIPC, a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development ...
Oregon to receive $15 million in settlement over baby powder lawsuit
Oregon Capital Chronicle via Yahoo News· 6 hours agoOregon will receive $15 million from Johnson & Johnson to settle allegations that the pharmaceutical...
Last patient in: Laminar Pharmaceuticals S.A. completes recruitment for CLINGLIO, the phase 2b/3...
Benzinga· 6 hours agoLaminar aims to submit regulatory filings or conditional marketing authorization by early 2025. PALMA DE MALLORCA, Spain, June 11, 2024 /CNW/ -- Laminar Pharmaceuticals S.A ...